Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cyclerion Therapeutics (CYCN) Exchange Rate Effect (2019 - 2024)

Cyclerion Therapeutics (CYCN) has 6 years of Exchange Rate Effect data on record, last reported at -$2000.0 in Q2 2024.

  • For Q2 2024, Exchange Rate Effect fell 166.67% year-over-year to -$2000.0; the TTM value through Mar 2025 reached -$2000.0, down 166.67%, while the annual FY2024 figure was -$6000.0, 175.0% down from the prior year.
  • Exchange Rate Effect reached -$2000.0 in Q2 2024 per CYCN's latest filing, up from -$4000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $8000.0 in Q4 2022 and bottomed at -$12000.0 in Q2 2020.
  • Average Exchange Rate Effect over 5 years is $142.86, with a median of $1000.0 recorded in 2021.
  • Peak YoY movement for Exchange Rate Effect: soared 400.0% in 2023, then plummeted 500.0% in 2024.
  • A 5-year view of Exchange Rate Effect shows it stood at $3000.0 in 2020, then changed by 0.0% to $3000.0 in 2021, then soared by 166.67% to $8000.0 in 2022, then tumbled by 50.0% to $4000.0 in 2023, then crashed by 150.0% to -$2000.0 in 2024.
  • Per Business Quant database, its latest 3 readings for Exchange Rate Effect were -$2000.0 in Q2 2024, -$4000.0 in Q1 2024, and $4000.0 in Q4 2023.